Intech Investment Management LLC purchased a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) in ...

Lung Disease Therapeutics Market. The global lung disease therapeutics market is on an impressive growth trajectory, ...

Swiss drugmaker Novartis will pay up to $2.9 billion for PTC Therapeutics' promising experimental drug for a neurological ...

Today, Benzinga's options scanner spotted 25 options trades for Teva Pharmaceutical Indus. This is not a typical pattern. The sentiment among these major traders is split, with 24% bullish and 60% ...

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, ...

Medincell (Paris:MEDCL) will hold a videoconference on Tuesday December 10th, 2024 to present the half-year financial results ...

While name brands like Adderall and Vyvanse may have been recently removed from the FDA Drug Shortage Database, it's unclear ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has received a consensus recommendation of “Moderate Buy ...

To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations. An archived version of the webcast will be available within ...